Theralase Technologies Inc. TLTFF

Primary Symbol: V.TLT

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 2025 Outlook

<< Previous

Bullboard Posts

Next >>

Comment by rollthedice10on Nov 20, 2024 12:44pm

158 Views

Post# 36322035

RE:RE:RE:RE:RE:RE:2025 Outlook

I agree, nothing will really happen until some positive news on BTD.
Securing BTD gives TLT a giant bargaining chip and I too think that
it is on the way. There is no way big pharma is not aware of what Theralase
has and where it could go. I would not be surprised if some prelimanary talks
are already under way. Not to put the cart before the horse, but I feel good.
Waiting and anticipating is tough, but certainly better than watching one of
your stocks slowly heading to the giant Venture Market graveyard. I've had a few.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant